AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation
Phyton Biotech, a German/North American Plant Cell Fermentation (PCF®) technology company, and AqVida, a German oncology Finished Dosage Formulation (FDF) manufacturer, are pleased to announce today that they have received European approval from the EDQM (European Directorate of Quality Medicines) for AqVida’s paclitaxel injectable FDF.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190418005161/en/
Phyton Biotech is the world’s leading manufacturer of paclitaxel active pharmaceutical ingredient (API), utilizing its prorprietary PCF® technology process. Under the strategic partnership with AqVida, Phyton Biotech will be the exclusive supplier of paclitaxel API for AqVida’s Taxol generic formulation, which is produced in AqVida’s new state-of-the-art injectable manufacturing facility located in Dassow, Germany. AqVida’s ultramodern robotic manufacturing line, designed for filling cytotoxic injectables, will be utilized to produce AqVida’s generic oncology medicines to treat common types of cancer.
“We chose to work with Phyton because of the company’s superior quality fermentation-produced API, in comparison to naturally extracted or semi-synthetically produced alternatives,” says Wolfgang Heinze, who is the Chief Executive Officer (CEO) of AqVida. “Approval of ourpaclitaxel injectable FDF by the European Directorate of Quality Medicines is a major milestone for our company.”
Recognized for its innovative and broad portfolio of generic oncology medicines, AqVida is a leading German oncology medication supplier that distributes its products globally.
“We are proud to partner with AqVida and assist with the expansion of its oncology product line,” says Colin Marr, president of Phyton Biotech. “Phyton is committed to working with trusted pharmaceutical partners who seek to improve the quality of oncology medicines.”
About Phyton Biotech
Phyton Biotech, a wholly-owned subsidiary of DFB Pharmaceuticals, is the global leader in Plant Cell Fermentation (PCF®) Technology, offering comprehensive services for the development and commercialization of plant-based molecules, extracts and recombinant products, serving the pharmaceutical, Chinese Traditional Medicine, Cosmetic, Agricultural and Food Ingredient industries. Using PCF®, Phyton Biotech offers a time-, risk- and cost-balanced path to commercially viable production processes, overcoming limitations often experienced with traditional plant extraction and chemical synthesis.
As a biotechnology leader with certified GMP facilities in Germany and Canada, Phyton Biotech has a successful track record of developing and implementing innovative contract development solutions for clients around the world. The company is now the world’s largest producer of paclitaxel and docetaxel via PCF®, with the capacity to meet more than one-third of the global demand for these critical active pharmaceutical ingredients. For more information, please visit phytonbiotech.com .
AqVida is a German pharmaceutical manufacturer of injectable finished dosage formulation (FDF) medications. Its mission is fully dedicated to, and specialized in, the development, registration, manufacturing and distribution of injectable FDF mainly for the oncology sector. It has developed a portfolio of injectable generic oncology medicines for treating the most common types of cancer. AqVida’s expertise in generic oncology products has made the company a leading partner in the pharmaceutical industry.
Julia Smith – Finch Media
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CA-GILEAD-SCIENCES23.8.2019 22:03:10 CEST | Press release
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
CA-ANDERSEN-TAX23.8.2019 14:18:12 CEST | Pressemeddelelse
Andersen Global debuterer i Colombia
KERING23.8.2019 09:49:11 CEST | Press release
32 Leading Global Fashion and Textile Companies Make Commitments on Climate, Biodiversity and Oceans
BITFLYER23.8.2019 07:02:02 CEST | Press release
Ethereum (ETH) Now Available on bitFlyer Buy/Sell
STALICLA23.8.2019 02:02:11 CEST | Press release
STALICLA Announces Completion of pre-IND Meeting With FDA on STP1 for Subgroup of Patients With Autism Spectrum Disorder (ASD)
NV-RIMINI-STREET,-INC.23.8.2019 00:02:07 CEST | Press release
San Fang Chemical Switches to Rimini Street Support for its Oracle EBS and Oracle Database Software
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom